Modal Labs
Optimizes AI inference to reduce compute costs and response time
$750MSeries D
ParticipantLC
Lux Capital
Activity from announced rounds
Activity in this selectionOct 17, 2026 · Sep 18, 2026
Lux Capital invests in companies emerging from the life sciences, physical sciences and computational sciences, including biotechnology, robotics, aerospace, defence and AI infrastructure.
Its investment approach includes small Seeds, Experiments and Optionality investments that let it engage with technology before a conventional venture case is established. The firm also makes thesis-driven investments and backs founders working on technically difficult problems.
Lux’s Riskgaming programme uses researched scenarios to examine how technological developments interact with geopolitics and national security. That perspective is especially relevant for founders whose commercial opportunity depends on scientific progress, industrial adoption or government demand.
Sources
- Rounds participated in
- 4
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $1.1B 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionMultiply Labs
Multiply Labs builds robotics for manufacturing personalized medicines, helping drug makers produce individualized treatments with less manual work.
$75MSeries B
ParticipantVarda
Varda builds spacecraft that manufacture materials in low Earth orbit and return them to Earth. Its capsules support microgravity pharmaceutical development and materials processing, followed by controlled reentry and post-flight analysis of returned payloads.
$251MSeries D
LeadW4 Games
Commercial tools and engineering services that help game studios build, optimize and ship projects made with the Godot Engine.
$18MSeries B
Participant